Ameriprise’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,019
Closed -$139K 4162
2025
Q4
$139K Sell
13,019
-44,817
-77% -$536K ﹤0.01% 3970
2025
Q3
$791K Sell
57,836
-18,965
-25% -$265K ﹤0.01% 3465
2025
Q2
$1.08M Buy
76,801
+6,322
+9% +$83.1K ﹤0.01% 3241
2025
Q1
$950K Buy
70,479
+6,050
+9% +$90.9K ﹤0.01% 3231
2024
Q4
$1.14M Sell
64,429
-1,093
-2% -$20.3K ﹤0.01% 3191
2024
Q3
$1.25M Buy
65,522
+4,463
+7% +$86K ﹤0.01% 3121
2024
Q2
$1.33M Sell
61,059
-25,301
-29% -$674K ﹤0.01% 3037
2024
Q1
$3.31M Sell
86,360
-4,936
-5% -$239K ﹤0.01% 2616
2023
Q4
$6.14M Buy
91,296
+2,843
+3% +$198K ﹤0.01% 2195
2023
Q3
$6.62M Buy
88,453
+7,587
+9% +$673K ﹤0.01% 2064
2023
Q2
$7.45M Buy
80,866
+3,774
+5% +$336K ﹤0.01% 2031
2023
Q1
$7.99M Buy
77,092
+388
+0.5% +$43K ﹤0.01% 1946
2022
Q4
$8.85M Buy
76,704
+2,323
+3% +$270K ﹤0.01% 1835
2022
Q3
$8.18M Sell
74,381
-5,973
-7% -$856K ﹤0.01% 1846
2022
Q2
$14.3M Buy
80,354
+26,868
+50% +$4.81M 0.01% 1460
2022
Q1
$9.14M Sell
53,486
-8,870
-14% -$1.67M ﹤0.01% 1979
2021
Q4
$13.1M Buy
62,356
+2,668
+4% +$551K ﹤0.01% 1754
2021
Q3
$11.5M Sell
59,688
-19,550
-25% -$4.81M ﹤0.01% 1738
2021
Q2
$22.4M Buy
79,238
+24,792
+46% +$6.72M 0.01% 1266
2021
Q1
$11.5M Sell
54,446
-63,724
-54% -$15.2M ﹤0.01% 1758
2020
Q4
$23.2M Buy
118,170
+20,602
+21% +$3.64M 0.01% 1133
2020
Q3
$16M Sell
97,568
-32,922
-25% -$5.42M 0.01% 1213
2020
Q2
$18.1M Sell
130,490
-97,281
-43% -$8.93M 0.01% 1114
2020
Q1
$14.2M Buy
227,771
+56,683
+33% +$5.16M 0.01% 1148
2019
Q4
$18.7M Buy
171,088
+36,640
+27% +$3.55M 0.01% 1245
2019
Q3
$13.9M Sell
134,448
-1,785
-1% -$192K 0.01% 1425
2019
Q2
$17.5M Sell
136,233
-9,128
-6% -$1.27M 0.01% 1277
2019
Q1
$19M Buy
145,361
+44,851
+45% +$5.69M 0.01% 1184
2018
Q4
$12.6M Buy
100,510
+14,240
+17% +$2.44M 0.01% 1406
2018
Q3
$19.1M Buy
86,270
+10,816
+14% +$2.19M 0.01% 1340
2018
Q2
$12.1M Buy
75,454
+3,272
+5% +$418K 0.01% 1587
2018
Q1
$6.75M Sell
72,182
-9,176
-11% -$686K ﹤0.01% 1956
2017
Q4
$5.68M Buy
81,358
+3,844
+5% +$255K ﹤0.01% 2038
2017
Q3
$4.6M Sell
77,514
-6,975
-8% -$347K ﹤0.01% 2146
2017
Q2
$3.5M Buy
84,489
+14,525
+21% +$631K ﹤0.01% 2317
2017
Q1
$3.1M Buy
69,964
+1,515
+2% +$65.2K ﹤0.01% 2358
2016
Q4
$2.85M Buy
68,449
+500
+0.7% +$20.1K ﹤0.01% 2450
2016
Q3
$2.57M Buy
67,949
+10,060
+17% +$361K ﹤0.01% 2429
2016
Q2
$1.93M Buy
57,889
+1,975
+4% +$63.7K ﹤0.01% 2544
2016
Q1
$1.69M Buy
55,914
+590
+1% +$17.2K ﹤0.01% 2600
2015
Q4
$1.68M Sell
55,324
-3,635
-6% -$108K ﹤0.01% 2698
2015
Q3
$1.58M Sell
58,959
-3,467
-6% -$101K ﹤0.01% 2744
2015
Q2
$2.02M Sell
62,426
-3,849
-6% -$122K ﹤0.01% 2751
2015
Q1
$1.99M Sell
66,275
-5,050
-7% -$160K ﹤0.01% 2598
2014
Q4
$2.39M Sell
71,325
-49,645
-41% -$1.55M ﹤0.01% 2479
2014
Q3
$3.97M Sell
120,970
-11,930
-9% -$366K ﹤0.01% 2173
2014
Q2
$4.04M Buy
132,900
+10,836
+9% +$338K ﹤0.01% 2200
2014
Q1
$3.55M Buy
122,064
+21,425
+21% +$574K ﹤0.01% 2241
2013
Q4
$2.63M Sell
100,639
-24,586
-20% -$630K ﹤0.01% 2345
2013
Q3
$3.37M Sell
125,225
-7,535
-6% -$202K ﹤0.01% 2186
2013
Q2
$3.42M Buy
+132,760
New +$3.49M ﹤0.01% 2089

Other funds holding MED

Ameriprise's MED Position: Q1 2026 in Review

Ameriprise sold out of Medifast (MED) in Q1 2026, closing a stake of 13,019 shares — an estimated $139K sold.

Ameriprise first reported a position in MED in Q2 2013 and held it in 51 quarters. The position peaked at $23.2M in Q4 2020. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Ameriprise reported no remaining Medifast position as of Q1 2026 after selling out during the quarter.
  • Ameriprise sold 13,019 Medifast shares in Q1 2026, an estimated $139K.
  • Ameriprise first reported a position in Medifast in Q2 2013 and held it in 51 quarters.
  • Ameriprise's Medifast position peaked at $23.2M in Q4 2020.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.